Reference
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Solerte, S. B., Di Sabatino, A., Galli, M., & Fiorina, P. (2020). Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetologica, 1. https://doi.org/10.1007/s00592-020-01539-z
0
0
Updated 2026-05-16
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Endocrine and metabolic aspects of the COVID-19 pandemic
Can Zn Be a Critical Element in COVID-19 Treatment?
The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19